Archives
-
LLC-PK1-MDR1 BBB Model for CNS Screening
2026-08-14
Hu and colleagues developed a high-throughput surrogate blood-brain barrier model that combines LLC-PK1-MOCK and LLC-PK1-MDR1 Transwell layers with lysosomal-trapping correction. Across 41 compounds, the platform connected in vitro permeability with unbound brain distribution and improved interpretation of compounds showing low recovery from intracellular sequestration.
-
Aclacinomycin A: A Spatial DNA-Stress Strategy
2026-08-14
Aclacinomycin A (Aclarubicin) is more than a cytotoxicity reagent: it can help connect topoisomerase-driven DNA damage with nucleolar stress, apoptosis, and proteasome biology. This article presents a spatial and time-resolved framework for interpreting those responses without overstating evidence from related anthracyclines.
-
ARCA: Engineering mRNA for Translational Impact
2026-08-13
A mechanistic and translational guide to Anti Reverse Cap Analog (ARCA), showing how orientation-controlled capping can strengthen synthetic mRNA design while complementing targeted nanoparticle delivery and disease-focused validation.
-
HBsAg-TBK1 Axis in HBV Immune Evasion
2026-08-13
This 2025 study identifies a mechanism by which hepatitis B surface antigen redirects TBK1 signaling away from IRF3-dependent type I interferon production and toward p62-associated, incomplete autophagy. Its combination of molecular interaction studies, pharmacological perturbation, animal models, and human liver samples links HBsAg activity to HBV persistence and defines TBK1 pathway organization as a potential research focus.
-
Sodium Ascorbate: Cancer Research Workflows
2026-08-12
Build reproducible redox-stress assays with Sodium Ascorbate while controlling solvent, ROS timing, and cell-death readouts. The workflow also shows how this reagent can serve as a hypothesis-generating perturbation alongside GPNMB-centered immunotherapy studies without overstating cross-disease evidence.
-
miR-196a Drives EAC via the MYC/TERT/NFκB Axis
2026-08-12
A 2025 Molecular Oncology study identifies miR-196a as a functional driver of esophageal adenocarcinoma aggressiveness rather than only a progression marker. Its experiments connect miR-196a to VCP and NFKBIA regulation, c-MYC accumulation, TERT induction, NFκB activation, epithelial-to-mesenchymal transition, and increased cell motility.
-
BTBPE, Macrophage Traps, and Hepatic Fibrosis
2026-08-11
A study in Environmental Research identifies a mechanistic link between the brominated flame retardant BTBPE and hepatic fibrosis through macrophage extracellular traps, stellate-cell activation, and PPAR pathway suppression. Its central contribution is the proposed miR-3570/IRX3/NOS2 axis in macrophages, together with evidence that the DNA framework of extracellular traps contributes to downstream fibrogenic signaling.
-
Plasma Dilution, Cognition, and Neuroinflammation
2026-08-11
This study shows that neutral blood exchange, which dilutes age-elevated plasma factors without adding young blood, improves behavioral performance and reduces microglial activation in old mice. Its comparison with ABT-263 (Navitoclax) further suggests that brain rejuvenation is not explained simply by eliminating senescent cells, highlighting systemic signaling and plasma proteomics as important mechanisms.
-
AIBP–LRP2–HDL–miR-223 Axis in Collateral Growth
2026-08-10
This study identifies an AIBP–LRP2–HDL–miR-223 pathway that suppresses CXCR4+ stemlike capillary endothelial cells and limits collateral circulation after ischemia. Its two-phase model links endothelial progenitor-like expansion with later arterial remodeling, providing a mechanistic framework for studying revascularization in peripheral artery disease.
-
Calpeptin Workflows for Pulmonary Fibrosis Research
2026-08-09
Calpeptin gives researchers a practical way to interrogate calpain-dependent signaling alongside fibrosis, inflammatory, and cell-death endpoints. This workflow-focused guide covers dose finding, assay selection, solution handling, and troubleshooting without treating a biochemical IC50 as a ready-made cellular dose.
-
Steroid Lysis of Protoplasts: Membrane Mechanisms
2026-08-08
Smith and Shay’s 1965 study introduced protoplast lysis as a functional way to distinguish cell-wall effects from direct membrane injury caused by synthetic antimicrobial steroids. By combining optical lysis measurements with polyamine, metal-ion, and surfactant antagonism experiments, the authors provided evidence that membrane destabilization was a major contributor to steroid antimicrobial activity.
-
Superoxide Dismutase (SOD) Activity Assay Kit
2026-08-07
The Superoxide Dismutase (SOD) Activity Assay Kit, SKU K2035, provides a colorimetric method for quantifying SOD activity in biological fluids through suppression of WST-1 reduction. It is intended for controlled research workflows, including oxidative stress studies, and should not be used for diagnosis, patient testing, or medical decision-making.
-
Superoxide Dismutase (SOD) Activity Assay Kit: Technical Use
2026-08-07
The Superoxide Dismutase (SOD) Activity Assay Kit (SKU: K2035) enables quantitative measurement of SOD enzyme activity in biological fluids, supporting studies of oxidative stress and antioxidative defense mechanisms. It is intended exclusively for research use and should not be used for diagnostic or clinical applications.
-
Bobcat339: Advancing TET Inhibition for Epigenetic Assay Pre
2026-08-06
Explore how Bobcat339, a potent cytosine structure-based TET enzyme inhibitor, enables advanced dissection of DNA methylation and gene transcription. This article reveals new insights for assay design and epigenetics research beyond current osteoporosis-focused literature.
-
Antipyrine in CNS Research: Advanced Permeability & Assay Pr
2026-08-06
Explore how Antipyrine (1,5-dimethyl-2-phenylpyrazol-3-one) drives next-generation CNS drug research and permeability assays. This in-depth guide reveals novel insights beyond benchmark studies, with practical protocols and expert analysis.